Entac Medical

Entac Medical is developing medical devices for predictive and diagnostic medicine based on a novel platform technology (audio spectral analysis). Its first application is PrevisEA, a late-stage Class II non-invasive, disposable device that has been clinically proven to predict postoperative ileus (POI) in surgical patients (25% of patients experience GI paralysis 2-6 days after surgery). Predicting the risk of ileus improves treatment options and patient outcomes while reducing readmission rates and saving hospitals millions of dollars in unnecessary treatment costs.